β-Blockers in Portal Hypertension An Overview
- 1 January 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 37 (2), 62-69
- https://doi.org/10.2165/00003495-198900372-00012
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomized clinical trial. The Italian Multicenter Project for Propranolol in Prevention of Bleeding.1988
- Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosisJournal of Hepatology, 1988
- Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: A prospective, randomized study†Hepatology, 1988
- Propranolol in the Prevention of First Upper Gastrointestinal Tract Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1987
- CONTROLLED TRIAL OF PROPRANOLOL FOR THE PREVENTION OF RECURRENT GASTROINTESTINAL-BLEEDING IN PATIENTS WITH CIRRHOSIS1987
- Propranolol for the prevention of recurrent variceal hemorrhage: A controlled trialHepatology, 1986
- Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliterationHepatology, 1986
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978